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Rickettsia conorii is the etiologic agent of Mediterranean
spotted fever, a re-emerging infectious disease with sig-
nificant mortality. This Gram-negative, obligately intracel-
lular pathogen is transmitted via tick bites, resulting in
disseminated vascular endothelial cell infection with vas-
cular leakage. In the infected human, Rickettsia conorii
infects endothelial cells, stimulating expression of cyto-
kines and pro-coagulant factors. However, the integrated
proteomic response of human endothelial cells to R.
conorii infection is not known. In this study, we performed
quantitative proteomic profiling of primary human umbil-
ical vein endothelial cells (HUVECs) with established R
conorii infection versus those stimulated with endotoxin
(LPS) alone. We observed differential expression of 55
proteins in HUVEC whole cell lysates. Of these, we ob-
served induction of signal transducer and activator of
transcription (STAT)1, MX dynamin-like GTPase (MX1),
and ISG15 ubiquitin-like modifier, indicating activation of
the JAK-STAT signaling pathway occurs in R. conorii-
infected HUVECs. The down-regulated proteins included
those involved in the pyrimidine and arginine biosynthetic
pathways. A highly specific biotinylated cross-linking en-
richment protocol was performed to identify dysregula-
tion of 11 integral plasma membrane proteins that included
up-regulated expression of a sodium/potassium trans-
porter and down-regulation of -actin 1. Analysis of Golgi
and soluble Golgi fractions identified up-regulated proteins
involved in platelet-endothelial adhesion, phospholipase
activity, and IFN activity. Thirty four rickettsial proteins were
identified with high confidence in the Golgi, plasma mem-
brane, or secreted protein fractions. The host proteins as-
sociated with rickettsial infections indicate activation of
interferon-STAT signaling pathways; the disruption of cel-
lular adhesion and alteration of antigen presentation path-
ways in response to rickettsial infections are distinct from
those produced by nonspecific LPS stimulation. These pat-
terns of differentially expressed proteins suggest mecha-
nisms of pathogenesis as well as methods for diagnosis
and monitoring Rickettsia infections. Molecular & Cel-
lular Proteomics 15: 10.1074/mcp.M115.054361, 289–304,
2016.
The genus Rickettsia contains non-motile, Gram-negative,
obligately intracellular alphaproteobacteria that are of global
medical and veterinary health importance due to their ende-
micity and re-emergence. From the clinical and antigenic
perspectives, rickettsial diseases are classified into two
groups, spotted fever and typhus. Nearly all of the numerous
spotted fever group rickettsiae are transmitted by ticks. The
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most virulent ones are Rickettsia rickettsii, the agent of Rocky
Mountain spotted fever, and Rickettsia conorii, the agent of
Mediterranean spotted fever (boutonneuse fever), a disease
prevalent throughout the Mediterranean, Africa, the Middle
East, and India. In humans, the spotted fevers present as
acute fever, headache, maculopapular rash, and vascular
leakage that can lead to significant morbidity and mortality
due to pulmonary and cerebral edema, particularly if there are
delays in diagnosis and treatment (1).
The characteristic leakage of intravascular fluid is a conse-
quence of the specific tropism of rickettsiae for endothelial
cells (1). Rickettsial organisms enter endothelial cells through
a calcium-dependent zipper-like entry mechanism involving
the actin cytoskeleton (2–4). Viable organisms subsequently
exit the phagosomes via phospholipase D and hemolysin
activities (5, 6), replicate in the cytoplasm, and exhibit early
intercellular spread as a consequence of directional actin
polymerization without detectable cellular injury (7–9).
Understanding the host response to Rickettsia infection has
been advanced by the development of a standardized model
of endothelial cell infection using primary human umbilical
vein cells (HUVECs)1 (10). In this model, infected endothelial
cells have been shown to express cytokines, interferons, cell
surface adhesion molecules such as E-selectin, VCAM-1,
ICAM-1 (11–13), and V3 integrin (14), and pro-coagulants
(tissue factor and von Willebrand factor) (15–17). These en-
dothelial cellular responses explain aspects of the pathobiol-
ogy of natural infections, including microvascular hemor-
rhage, endothelial leakage, and multiorgan failure (1).
An integrated understanding of the endothelial cellular re-
sponse is not yet available. To address this question, we have
undertaken a study of the global endothelial cell proteomic
response to infection with R. conorii using quantitative pro-
teomic profiling of R. conorii-infected HUVECs, including the
analysis of plasma membrane and secreted proteins within
the Golgi apparatus. Our experimental design was to use
trypsin-mediated exchange of stable isotopes of H2O to
quantify differences in protein expression of primary HUVECs
infected with R. conorii versus those stimulated with LPS
alone to control for nonspecific inflammatory effects. In whole
cellular lysates, we observed that R. conorii-infected endo-
thelial cells significantly up-regulated the JAK-STAT signaling
pathway. By contrast, analysis of PM and Golgi fractions
revealed up-regulation of platelet adhesion proteins and
down-regulation of integrin/cadherin components. To identify
proteins secreted by R. conorii-infected HUVECs, soluble
Golgi fractions were analyzed. Here, we observed significant
induction of HLA and 2-microglobulin, providing insights into
major histocompatibility complex (MHC)-I-mediated antigen
processing, important in the host cytotoxic T cell response.
Finally, 34 rickettsial proteins were identified with high confi-
dence in the Golgi apparatus, PM, or secreted protein frac-
tions. These studies advance the understanding of the endo-
thelial response to R. conorii infection through up-regulation
of IFN- and MHC class I antigen presentation pathways and
implications of the secretome for the host response and
diagnostics.
EXPERIMENTAL PROCEDURES
Materials—Link sulfosuccinimidyl-2-(biotinamido) ethyl-1,3-dithio-
propionate (Sulfo-NHS-SS-Biotin) was from Pierce (Thermo Scien-
tific, San Jose, CA). NanoLinkTM streptavidin magnetic beads (0.8
m) were from Solulink, San Diego, CA (catalog no. M-1002); prote-
ase inhibitor mixture was from Sigma, St. Louis, MO (catalog no.
P8340). LPS was from Escherichia coli 0111:B4 (Sigma).
Cell Cultures—Pools of HUVECs were established from individual
human umbilical cords grown in supplemented EGM-2 medium
(Lonza). The cells were subcultured when the monolayer became
confluent two or three times per week. In this study, the cells were
used between passages 3 and 4. For infection, 15  106 primary
HUVECs in T175 flasks were infected in BSL-3 containment, and
subsequently lysates were prepared 10 days later and were inacti-
vated in accordance with University of Texas Medical Branch IBC-
approved protocols. Cellular infection was verified by immunofluores-
cent microscopy using a rabbit polyclonal serum against R. conorii
and anti-rabbit IgG conjugated to Alexa 594 (Life Technologies, inc.).
HUVECs were stimulated with LPS (50 ng/ml) overnight as controls.
Rickettsia—R. conorii (Malish 7 strain) was obtained from the
American Type Culture Collection (ATCC; Manassas, Va.; catalog no.
VR-613). The stock, aliquots of a 10% suspension of infected yolk sac
containing 4  106 pfu per ml, was stored at 70 °C.
Experimental Design and Statistical Rationale—HUVECs were in-
fected with R. conorii and subjected to whole cell lysate, plasma
membrane, and Golgi fractionation. Experiments were replicated
twice. For each quantitative LC-MS/MS analysis, samples were sub-
jected to label swapping as described below.
Plasma Membrane (PM) Preparation—LPS-stimulated or R. cono-
rii-infected HUVECs were washed three times with PBS (37 °C) con-
taining calcium and magnesium. PM proteins were cross-linked 15
min in 10 ml of PBS with 10 l of EZ-Link Sulfo-NHS-SS-Biotin stock
solution (100 mg/ml, freshly prepared in DMSO) as described previ-
ously (18). Afterward, cross-linker was quenched by addition of 5 ml
of lysine solution (1 mg/ml), washed in ice-cold wash buffer (250 mM
sucrose, 10 mM Tris, pH 7.4), and resuspended in ice-cold homoge-
nization buffer (250 mM sucrose, 10 mM Tris, pH 7.4, 1:100 dilution of
protease inhibitor (Sigma P8340), 1 mM NaF, and 1 mM Na3VO4). The
cells were concentrated by centrifugation (10 min at 800  g at 4 °C),
resuspended in homogenization buffer, and Dounce homogenized
using 15 strokes of pestle A and 10 strokes of pestle B. The homo-
genate was then centrifuged (10 min at 1,000  g, 4 °C), and mem-
branes were captured by addition of suspended streptavidin mag-
netic beads (15 ml/T165 flask) followed by gentle mixing at 4 °C for
1 h and magnetic capture. The membrane-bound streptavidin beads
were then washed with 1 M KCl (high salt wash) three times, followed
by washing in 0.1 M Na2CO3, pH 11.5 (high-pH wash), and then
ice-cold hypotonic buffer (10 mM HEPES, pH 7.5, 1.5 mM MgCl2, 10
mM KCl, 1:100 dilution of protease inhibitor mixture, 1 mM NaF, and 1
mM Na3VO4). The streptavidin beads were resuspended in twice their
volume of 2 SDS sample buffer containing 100 mM dithiothreitol
1 The abbreviations used are: HUVEC, human umbilical vein endo-
thelial cell; FDR, false discovery rate; IPA, Ingenuity Pathway Analysis;
PM, plasma membrane; SID, stable isotopic dilution; SRM, selected
reaction monitoring; WCL, whole cell lysate; STAT, signal transducer
and activator of transcription; NSAF, normalized spectral abundance
factor; SAF, spectral abundance factor; ACN, acetonitrile; SIS, stable
isotope standard.
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(DTT). After vortexing, beads were removed with a strong magnet,
and the supernatant was saved. The proteins in the supernatant were
separated by SDS-PAGE and visualized with Colloidal Blue (Life
Technologies, Inc.). The gel in each lane was cut into small slices. The
proteins were digested with trypsin in-gel as described previously.
Briefly, the gel particles were destained in 1 ml of water/methanol
solution (50:50, v/v) containing 25 mM NH4HCO3, pH 8.0, three times,
changing the solution every 10 min. The destained gel was then
washed in 1 ml of an acetic/methanol solution (acetic acid/methanol/
water, 10:40:50, v/v/v) for 3 h, with the solution changed every 1 h.
The resulting gel was soaked in 1 ml of water for 40 min, changing the
solvent twice every 20 min. The gel was then transferred into a 0.5-ml
microcentrifuge tube and dehydrated by soaking the gel in 100%
acetonitrile (ACN) until it became opaque white. The solution was
removed, and the gel was dried in a SpeedVac for 20–30 min. The
dried gel was rehydrated with an adequate amount of trypsin diges-
tion solution (10 ng of trypsin/l in 50 mM NH4HCO3, pH 8.0). The
digestion was carried out at 37 °C overnight. To extract tryptic digest,
the gel was soaked in 40 l of extraction solution (ACN/trifluoroacetic
acid/water, 50:5:45, v/v/v) for 60 min with vortexing. The extraction
solution was then carefully removed with a gel-loading pipette tip, and
the extraction was repeated once. The extracts were pooled and
dried with a SpeedVac. The tryptic peptides were used for trypsin-
catalyzed 18O labeling.
Golgi Preparation—Golgi preparations were performed as de-
scribed (19). In brief, the flow-through of the magnetic bead separa-
tion from above was adjusted to a final concentration of 1.4 M sucrose
by addition of 2.0 M sucrose and transferred to SW41 centrifuge
tubes. Samples were overlaid with 4 ml of 1.2 M sucrose solution,
topped off with 0.8 M sucrose solution, and spun at 38,000 rpm in an
SW41Ti rotor (246,000  g) for 90 min at 4 °C. Crude Golgi prepara-
tions were harvested from the 0.8/1.2 M sucrose interface. An aliquot
was assayed for total protein concentration by the bicinchoninic acid
(BCA) assay (Thermo Scientific).
Golgi Extracts—An equal volume of 1 M KCl was added to the
crude Golgi preparation, incubated for 25 min with rotation at 4 °C,
and an equal amount of ice-cold Dulbecco’s modified PBS (D-PBS)
added to each tube. The Golgi preparations were spun at 40,000 rpm
(271,000  g) at 4 °C. The membranes were then resuspended in 0.5
l/g of protein of crude extract using a 100 mM ammonium carbon-
ate solution, pH 11.0. Membranes were removed by centrifugation at
40,000 rpm (271,000  g) for 60 min at 4 °C. The soluble superna-
tants, representing the secreted proteins, were denatured by addition
of an equal volume of 8 M guanidine HCl. Insoluble membranes were
subjected to SDS-PAGE, and digested with trypsin in-gel as de-
scribed above.
Trypsin Digestion of Whole Cell Lysate and Secreted Proteins—50
g of protein were reduced with 10 mM DTT for 30 min at room
temperature. Protein cysteinyl residues were alkylated with 30 mM
iodoacetamide for 2 h at 37 °C. Each sample was diluted 1:10 with
100 mM ammonium bicarbonate and digested with 40 g of trypsin
overnight at 37 °C, and each tryptic peptide mixture was desalted
with a Sep-Pak C18 cartridge (Waters, Milford, MA) following the
manufacturer’s instructions. Peptides were eluted from the cartridge
with 80% acetonitrile and completely dried using a Speedvac.
Trypsin-catalyzed 16/18O Labeling—The tryptic digest of each sam-
ple was divided into two parts of equal volume. One part was labeled
with [18O]H2O, the other part remained unlabeled (
16O-H2O). Peptide
C-terminal 16O/18O labeling was performed as described previously
(20, 21). The dried peptide samples were redissolved with 3 l of
anhydrous acetonitrile, 10 mg of immobilized trypsin (Applied Biosys-
tems, CA), and 200 l of normal water (H2
16O) or heavy water H2
18O
containing 50 mM ammonium bicarbonate was added to the Rickett-
sia-infected and LPS control peptides, respectively, and both sam-
ples were incubated for 48 h at 37 °C. Supernatants were collected
using a spin column and mixed as follows: 18O-labeled peptides from
Rickettsia-treated sample mixed with 16O-labeled peptides from LPS
particle-treated sample (forward labeling); 16O-labeled peptides from
Rickettsia-treated sample mixed with 18O-labeled peptides from LPS
particle-treated sample (reverse labeling). After mixing, the samples
were desalted with a SepPak C18 cartridge (Waters). The desalted
peptides were stored at 80 °C for LC-MS/MS analysis.
LC-MS/MS Analysis—Dried peptide samples were redissolved in 2
l of acetonitrile and diluted with 40 l of 0.1% formic acid. LC-
MS/MS analysis was performed with a Q Exactive Orbitrap mass
spectrometer (Thermo Scientific, San Jose, CA) equipped with a
nanospray source with an on-line Easy-nLC 1000 nano-HPLC system
(Thermo Scientific, San Jose, CA). Ten microliters of each peptide
solution were injected and separated on a reversed phase nano-
HPLC C18 column (75 m  150 cm) with a linear gradient of 0–35%
mobile phase B (0.1% formic acid, 90% acetonitrile) in mobile phase
A (0.1% formic acid) over 120 min at 300 nl/min. The mass spectrom-
eter was operated in the data-dependent acquisition mode with a
resolution of 70,000 at full scan mode and 17,500 at MS/MS mode.
The 10 most intense ions in each MS survey scan were automatically
selected for MS/MS. The acquired MS/MS spectra were analyzed by
1.4 (22) using default parameters (supplemental File 1) in the Swiss-
Prot human protein databases (downloaded on February 2013,
20,247 protein entries) using a mass tolerance of 20 ppm for pre-
cursor and product ions and a static mass modification on cysteinyl
residues that corresponded to alkylation with iodoacetamide. Differ-
ential modifications were defined to be 18O-labeled C-terminal and
oxidized methionine with a maximum of two missed cleavages. Pro-
tein identification data (accession numbers, peptides observed, se-
quence coverage) are in supplemental Tables 1–3. Annotated spectra
of host proteins identified with single peptides are in supplemental file
2. Annotated spectra of rickettsial proteins identified with single pep-
tides are in supplemental file 3. The FDR cutoff for peptide and protein
identification is 0.01.
Data Processing—For each subcellular fraction, the experiments
were repeated after swapping the 18O-labeling between Rickettsia-
infected cells and LPS-treated cells. This label swapping strategy
allows for detection of irreproducible ratios that might arise due to
interference in precursor quantification provided there is a minimum
of two biological replicates. Each dataset was first centered by sub-
tracting the most frequent value in that dataset and then subjected to
MaxQuant Significant A analysis (22). Next, the forward and reverse
datasets were plotted with forward log2 heavy/light (H/L) ratio (x axis)
against reverse log2 H/L ratio (y axis). Only the proteins that have a
Significant A p value below 0.05 and also located in either upper-left
or lower-right quadrant are considered to be the significantly ex-
pressed proteins.
The normalized spectral abundance factor (NSAF) value for each
protein was calculated as described (23) in Equation 1,
NSAFk
 IL
k
i1N  IL
i
(Eq. 1)
where the total MS intensity (I) of the matching peptides from protein
k was divided by the protein length (L) and then divided by the sum of
I/L for all uniquely identified proteins in the dataset.
Stable Isotope Dilution (SID)-selected Reaction Monitoring (SRM)-
MS—The SID-SRM-MS assays were developed as described previ-
ously (24, 25). For each targeted protein, two or three peptides were
initially selected and then the sensitivity and selectivity of these were
experimentally evaluated as described previously (24, 25). The pep-
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tide with the best sensitivity and selectivity was selected as the
surrogate for that protein. For each peptide, 3–5 SRM transitions were
monitored. The signature peptides and SRM parameters are listed in
Table VI. The peptides were chemically synthesized incorporating
isotopically labeled [13C6
15N4]arginine or [
13C6
15N2]lysine to a 99%
isotopic enrichment (Thermo Scientific). The amount of stable isotope
standard (SIS) peptides was determined by amino acid analysis. The
tryptic digests were then reconstituted in 30 l of 5% formic acid,
0.01% TFA. An aliquot of 10 l of 50 fmol/l diluted SIS peptides was
added to each tryptic digest. These samples were desalted with a
ZipTip C18 cartridge. The peptides were eluted with 80% ACN and
dried. The peptides were reconstituted in 30 l of 5% formic acid,
0.01% TFA and were directly analyzed by LC-SRM-MS. LC-SRM-MS
analysis was performed with a TSQ Vantage triple quadrupole mass
spectrometer equipped with nanospray source (Thermo Scientific,
San Jose, CA). 8–10 targeted proteins were analyzed in a single
LC-SRM run. The on-line chromatography was performed using an
Eksigent NanoLC-2D HPLC system (AB SCIEX, Dublin, CA). An ali-
quot of 10 l of each of the tryptic digests was injected on a C18
reverse-phase nano-HPLC column (PicoFritTM, 75 m  10 cm; tip
inner diameter of 15 m) at a flow rate of 500 nl/min over 20 min in
98% buffer A (0.1% formic acid), followed by a 15-min linear gradient
from 2 to 30% mobile buffer B (0.1% formic acid, 90% acetonitrile).
The TSQ Vantage was operated in high resolution SRMmode with Q1
and Q3 set to 0.2 and 0.7-Da full width half-maximum. All acquisition
methods used the following parameters: 2100 V ion spray voltage, a
275 °C ion-transferring tube temperature, and a collision-activated
dissociation pressure at 1.5 millitorr. The S-lens voltage used corre-
sponded to the value in S-lens table generated during MS calibration.
All SRM data were manually inspected to ensure peak detection
and accurate integration. The chromatographic retention time and the
relative product ion intensities of the analyte peptides were compared
with those of the SIS peptides. The variation of the retention time
between the analyte peptides and their SIS counterparts should be
within 0.05 min, and the difference in the relative product ion inten-
sities of the analyte peptides and SIS peptides were below 20%. The
peak areas in the extract ion chromatography of the native and SIS
version of each signature peptide were integrated using Xcalibur 2.1.
The default values for noise percentage and baseline subtraction
window were used. The ratio between the peak area of native and SIS
version of each peptide was calculated.
Bioinformatics Analysis—High confidence protein identifications
were subjected to pathway enrichment analysis using the Protein
ANalysis THrough Evolutionary Relationship (Panther) pathway clas-
sification system (26). Pathways are rank-ordered based on statisti-
cally significant enrichment of the number of proteins in the dataset
relative to the total number of proteins in the pathway. Ingenuity
Pathway Analysis (IPA) was performed to identify relevant networks,
rank-ordered by the number of proteins in the dataset relative to the
pathway.
RESULTS
Experimental Design—To obtain a global understanding of
the endothelial proteomics response to Rickettsia infections,
we applied a standardized model developed by us using R.
conorii-infected HUVECs, cells selected because they repre-
sent the primary target of R. conorii infection in vivo. Whole
cell lysates (WCLs), PM, and Golgi fractions were prepared
from uniformly R. conorii-infected primary HUVECs (Fig. 1A).
In this experiment, conditions were established such that the
cells were uniformly infected at the time of harvest (Fig. 1B).
Quantitative stable isotopic labeling LC-MS/MS analysis was
performed using trypsin-mediated 18O exchange and was
compared with LPS-stimulated HUVECs to control for inflam-
matory responses that are not specific to rickettsial infection.
For each pairwise comparison, the experiment was re-
peated after swapping the 18O labeling between R. conorii-
infected and LPS-stimulated HUVECs. Before the heavy- and
light-labeled peptides were mixed, a small fraction of the
18O-labeled sample was tested for 18O-labeling efficiency
with LC-MS/MS. Based on the analysis, the 18O-labeling ef-
ficiency is higher than 95% based on the abundance of two
18O-labeled peptides and their 16O-labeled counterparts. For
FIG. 1. Quantitative proteomics study of R. conorii infection in HUVECs. A, experimental strategy. Shown is a schematic diagram of the
experimental work flow for the identification of differential protein expression control (LPS-stimulated) or R. conorii-infected HUVECs. B,
immunofluorescence assay. Immunofluorescence assay for rickettsial antigen (red) and nuclear DNA (blue) in HUVECs smeared on a glass slide
to determine rickettsial growth. Original objective magnification was40. The primary antibody was a rabbit anti-R. conorii immune serum. The
secondary antibody was a donkey anti-rabbit labeled with Alexa 546. C, 18O-labeling efficiency. MS spectra of two 18O-labeled peptides
(HSPB1, LATQSNEITIPVTFESR, and ANXA2, GVDEVTIVNILTNR) are shown.
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example, in the whole cell lysate 18O quantification experi-
ment, a total of 3,242 peptides were identified with 1% FDR
by forward labeling. Among these, 3,127 (96.5%) were pep-
tides with double-incorporated 18O labels. Out of 5,938 pep-
tides in the reverse labeling experiment, 5,845 (98.4%) were
double-incorporated with 18O labels. We further inspected the
spectra manually. As shown in Fig. 1C, the 18O-labeling effi-
ciency was higher than 95% based on the abundance of two
18O-labeled peptides and their 16O-labeled counterparts.
Differentially Expressed Proteins Identified from WCLs—In
WCLs, a total of 1,082 proteins were quantified in both the
forward and reversed 18O-labeling experiments, resulting in
784 high confidence proteins quantified (Fig. 2). A total of 55
proteins was differentially expressed (Fig. 2A), with 31 being
up-regulated (Table I). The Pearson correlation of the quanti-
tation of these significantly differentially expressed proteins
between the two replicates is 0.68.
To understand the biological pathways affected by R. cono-
rii infection, we subjected the data to pathway enrichment
analysis using the Panther pathway classification system (see
under “Experimental Procedures”). This classification is a sim-
plified functional ontology of functional protein groups based
on curated data linked by Hidden Markov Models, allowing for
more accurate functional inferences (26). In this representa-
tion, pathways enriched in the data set are presented as a
rank-ordered list based on the percentage of the proteins
within the pathway that are represented in the observed data
set. We noted that the 31 up-regulated proteins are found
within 13 pathways (Fig. 2B, top panel); Parkinson disease,
FGF signaling, JAK-STAT pathways, interleukin signaling, and
chemokine/cytokine inflammation pathways are enriched.
The pathways represented by the down-regulated proteins
were RNA polymerase I, arginine biosynthesis, and de novo
pyrimidine biosynthesis (Fig. 2B, bottom panel), suggesting
that R. conorii infection significantly perturbs metabolic path-
ways in HUVECs.
IPA was performed on the 55 differentially expressed pro-
tein WCLs. One of the top-ranked networks enriched in this
fraction was Molecular Transport and Protein Trafficking, con-
taining a cluster of IFN-signaling proteins, including MX1,
ISG3, STAT1, and ISG15 (Fig. 2C), consistent with the Panther
pathway analysis.
Differentially Expressed PM Proteins—Previous work has
shown that R. conorii induces significant changes in the ex-
pression of cell surface proteins, including tissue factor (16)
and adhesion molecules (11–14), promoting a pro-thrombotic
phenotype. Because PM proteins are under-represented inFIG. 2. Differential protein expression in R. conorii-infected
HUVEC WCLs. A, quantification of regulation. The plots are log2-
transformed forward and reverse heavy/light ratios of individual pro-
teins quantitated in WCLs from each replicate. Up-regulated proteins
identified from the R. conorii-infected HUVECs are located in the
bottom-right quadrant (red circles), and the proteins down-regulated
in Rickettsia-infected HUVECs are located in the upper-left quadrant
(green squares). B, Panther pathway analysis. Top panel, top path-
ways for proteins enriched in HUVEC WCL identified by the Panther
classification system. x axis is the percentage of the pathway repre-
sented in the identified proteins. Bottom panel is pathway analysis for
proteins depleted in HUVEC WCLs. C, network by IPA. Shown is the
top-ranked network of differentially expressed WCL proteins identi-
fied in the Ingenuity Knowledge base. For each node, red indicates
up-regulation in Rickettsia-infected cells; green, down-regulation. For
abbreviations, see Table I.
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TABLE I
Proteins with altered abundances in HUVEC WLCs
For each significantly regulated protein is shown the accession number (Acc #), protein name, common gene name, and mean heavy (H)/light (L)
enrichment ratio for the stable isotopic quantification in the replicate measurements. The L/H ratio measured after the label swap experiment is also
shown.
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total cellular lysates, we separately analyzed the integral
membrane proteome of R. conorii-infected HUVECs. For this
purpose, we applied a biotin-directed affinity purification
method developed by us for the preparation of integral PM
proteins (18). A total of 286 plasma membrane proteins were
quantified (Fig. 3). We used NSAF to confirm the enrichment
of the plasma membrane proteins. NSAF is based on spectral
counting, which has been widely used in label-free proteom-
ics quantitation (27–29). In spectral counting, larger proteins
usually generate more peptides and therefore more spectral
counts than smaller proteins. Therefore, the number of spec-
tral counts for each protein is first divided by the mass or
protein length, which defines the spectral abundance factor
(SAF). Furthermore, to accurately account for sample to sam-
ple variation, individual SAF values are normalized to one by
dividing by the sum of all SAFs for proteins identified in the
sample, resulting in the NSAF value (23). In this manner,
NSAFs values are standardized across distinct samples, al-
lowing direct comparisons to be made between individual
samples. The NSAF value of one protein is positively corre-
FIG. 3. Differential protein expression in R. conorii-infected HUVEC PM fractions. A, enrichment analysis. Top, spectral count
measurements (NSAF) for representative plasma membrane proteins in the PM and WCL fractions. Note the enrichment of plasma membrane
in the PM fractions. Bottom left panel, NSAF for cytosolic proteins, which are reduced (depleted) in PM fractions. Bottom right panel, NSAF
for representative mitochondrial, endoplasmic reticulum, and nuclear proteins, also depleted in PM fractions. B, quantification of regulation.
Shown are up-regulated proteins in PM fractions from Rickettsia-infected HUVECs in the bottom-right quadrant (red), and the proteins
down-regulated in Rickettsia-infected HUVECs are located in the top-left quadrant (green). C, Panther pathway analysis. Top panel, highest
ranked pathways identified by the Panther classification system for proteins enriched in HUVEC PMs. Bottom panel, pathways associated with
down-regulated PM proteins. D, IPA network. Shown is the top-ranked network (“organismal disease”) of PM proteins in the IPA Knowledge
Base. Abbreviations are shown in Table II.
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lated with the relative abundance of the protein in this sample,
where a highly abundant protein would have a higher NSAF
value. We calculated the NSAF value for each protein identified
in the PM fraction and whole cell lysate and then we compared
their NSAF scores in the PM fraction and WCLs. As shown in
Fig. 3A, compared withWCLs, plasmamembrane proteins were
highly enriched in the PM fraction, whereas the highly abundant
cytosolic proteins HSP90AB1, HSPB1, and ENO1 were almost
completely removed from our PM fraction. Proteins specific to
the mitochondria (LDHA and LDHB), endoplasmic reticulum
(VCP), and nucleus (NPM1 and NCL) were also significantly
depleted from the PM fraction, indicating that we have success-
fully enriched the plasma membrane fraction.
Among 286 quantified PM proteins, a total of 11 differen-
tially expressed proteins was identified (Fig. 3B). The Pearson
correlation of the quantitation of these significantly differen-
tially expressed proteins between the two replicates is 0.80.
Four of these PM proteins were up-regulated by R. conorii
infection (Table II). These proteins included hyperpolarization-
activated potassium channel (HCN1) and 5-nucleotidase. We
noted that the most down-regulated PM protein was -actin 1
(ACTA1), suggesting that R. conorii infection depletes PM
ACTA1 as part of its effect on adherens junction formation
and stress fiber formation Rickettsia (2, 8, 9, 30).
To more globally understand the functions controlled by
this coordinated up-regulation of cell surface proteins, we
subjected the differentially expressed proteins to enrichment
analysis. Interestingly, proteins involved in purine and pyrim-
idine metabolism pathways were present in the up-regulated
protein data set (Fig. 3C, top panel). Importantly, proteins
controlling Wnt signaling, endothelin signaling, and cadherin
signaling were in the down-regulated data set, among others
(Fig. 3C, bottom panel). The effect of R. conorii on cadherin
signaling may explain previously observed vascular leak phe-
nomena and the effect on endothelial cell adherens junctions
(1, 30). An IPA analysis showed a single network, “organismal
disease” populated by down-regulated ACTA1 and the up-
regulated HCN1 (Fig. 3D).
Differentially Expressed Golgi Proteins—Endothelial cells in-
fected with R. conorii inducibly secrete a variety of soluble
mediators. To better understand these, we profiled Golgi-en-
riched fractions containing proteins being processed for the
secretory pathway. In this analysis, both total and soluble Golgi
fractions were subjected to quantitative proteomic profiling. A
total of 499 Golgi proteins were quantified; of these, 336 pro-
teins were quantified in both experiments (supplemental Fig. 3).
We used NSAF values to evaluate the enrichment of Golgi
proteins and the proteins regulating the secretory pathways. As
shown in Fig. 4A, Golgi apparatus protein 1 (GLG1) and several
proteins of Golgi-derived retrograde transport vesicles such as
SEC22B and three members of p24 family (TMED10, TMED3,
and TMED7) were enriched in the Golgi fraction. Transmem-
brane emp24 domain-containing proteins are a widely con-
served family of transmembrane proteins that play a functional
role in protein transport within the early secretory pathway.
Among the 336 quantified proteins, a total of 52 differen-
tially expressed proteins were identified (Fig. 4B), including 25
up-regulated proteins. The Pearson correlation of the quanti-
tation of these significantly differentially expressed proteins
between the two replicates is 0.88. These proteins included
cell surface proteins PECAM, HLA-C, annexin, and others
(Table III). We also noted interferon-induced transmembrane
protein (IFITM)-3, consistent with the activation of the IFN-
JAK-STAT signaling pathway observed in the WCL fractions.
Enriched pathways of the up-regulated proteins in the Golgi
membranes included GABA-type B protein receptor signaling
and endogenous cannabinoid signaling (Fig. 4C, top panel).
The down-regulated proteins in the Golgi fractions repre-
sented Huntington disease, Rho GTPase, and cadherin-sig-
naling pathways (Fig. 4C, bottom panel). The depletion of
cadherins in the Golgi pathway is consistent with the reduc-
tion of cadherins in the PM fractions noted earlier. An IPA
analysis showed a network linked to cell-cell signaling and
cellular compromise, including von Willebrand factor, flotillin
(FLOT1), annexin A2 (ANXA2), phospholipase D3 (PLD3),
HLA-C, and others (Fig. 4D).
TABLE II
Differentially expressed PM proteins
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Differentially Expressed Soluble Golgi Proteins—To identify
secreted proteins processed by the canonical secretory path-
way, we separately analyzed changes in soluble Golgi protein
proteomes; 371 proteins were identified in soluble Golgi ex-
tracts, with 216 proteins being quantified in both experiments
(supplemental Fig. 4). We used NSAF values to evaluate the
enrichment of secreted proteins in this fraction. As shown in Fig.
5A, extracellular proteins such as secreted protein, acidic, cys-
teine-rich (SPARC), fibronectin (FN1), Intercellular Adhesion
Molecule (ICAM)-1, Connective Tissue Growth Factor (CTGF),
Prosaposin (PSAP), and Golgi Glycoprotein 1 (GLG1) were en-
riched in this fraction. These proteins included HLA class I,
PECAM, and 2-microglobulin (Table IV).
In the Golgi fraction, a total of 13 differentially expressed
proteins were identified (Fig. 5B); of these, six were up-regu-
lated by Rickettsia infection (Table V). The Pearson correlation
of the quantitation of these significantly differentially ex-
pressed proteins between the two replicates is 0.86. To pro-
vide some biological insight into the activities of these se-
creted proteins, the up-regulated proteins were subjected
to a protein class analysis. The most abundant protein
activities of the secreted proteins were those encoding
classes of cell adhesion/cell junction activity and hydrolase
and protease activity (Fig. 5C). IPA analysis identified a
pathway dominated by 2-microglobulin MHC class I and
HLA isoforms (Fig. 5D).
Intracellular Distribution of Rickettsial Proteins—Rickettsia
invade eukaryotic cells through an induced phagocytosis
mechanism. The bacteria then escape from the phagosome
and utilize actin filaments to spread (even to the nucleus) and
FIG. 4.Differential protein expression inR. conorii-infected HUVECGolgi fractions. A, enrichment analysis. NSAF for selected Golgi proteins
in HUVEC Golgi and WCL fractions. Note the high spectral counts in the Golgi fractions relative to that in WCL fractions. B, quantification of
regulation. Golgi proteins up-regulated in Rickettsia-stimulated HUVECs are located in the bottom-right quadrant (red), the Golgi proteins
down-regulated in Rickettsia stimulated cells are located in the upper left (green). C, Panther pathway analysis. Top panel, top ranked pathways
for proteins enriched in HUVEC Golgi fractions. Bottom panel, pathway analysis for proteins depleted in HUVEC Golgi fractions. D, IPA network
analysis. Shown is the top-ranked network (“cell-cell signaling and compromise”) of Golgi proteins in IPA. Abbreviations are shown in Table III.
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replicate in the host cell cytoplasm and nucleus. However, the
subcellular distribution of Rickettsia proteins has not yet been
determined to our knowledge. Unmatched spectra from our
proteomics study were searched against the Rickettsia pro-
teome database (downloaded from SwissProt protein data-
base on February 20, 2013, 4,189 entries); 34 proteins were
identified with a false discovery rate estimation of 1% or less
in the PM, Golgi, and secreted protein fractions (Table V).
These proteins show a characteristic non-random distribu-
tion. For example, the Rickettsia chaperone proteins, HtpG,
DnaK, NADPH reductase, and cytosolic aminopeptidase,
were enriched in the Golgi fractions, consistent with either
contamination of Golgi fraction with Rickettsia organisms or
biological processing of rickettsial proteins by the host Golgi
pathway. The cytochrome c oxidase and NADH-quinone oxi-
doreductases were observed in the Golgi preparations, per-
haps suggesting that these molecules may be a source of
enhanced superoxide and lipid peroxidation observed in Rick-
ettsia-infected endothelial cells (31).
A large number of R. conorii proteins was identified in the
soluble fraction of the Golgi preparation and some of these
included ferredoxin, heme biosynthetic enzymes, peptide
chain releasing factors, protein translocases, and others (Ta-
ble V). In the soluble Golgi fractions, we also identified the cell
surface antigen Sca2, a formin mimic responsible for interact-
ing with the host actin cytoskeleton (32). Finally, a distinct
group of R. conorii proteins was identified in HUVEC plasma
membrane fractions; these proteins were putative ligases,
dehydrogenases, glycoprotein transferases, and lipoprotein-
metabolizing proteins (Table V).
Verification of Host- and Rickettsial Proteins—To qualify
the differential expression of endothelial innate response
TABLE III
Golgi proteins with altered abundances in response to R. conorii infection and LPS stimulation
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FIG. 5. Differential expression of secreted proteins in R. conorii infection. A, enrichment analysis. NSAF for selected secreted
proteins in soluble Golgi fraction relative to WCL fractions. Note the high spectral counts in the soluble fractions relative to that in
WCLs. B, quantification of regulation. Secreted proteins identified in soluble Golgi fraction. Proteins up-regulated in Rickettsia-infected
HUVECs are located in the bottom-right quadrant (red), and down-regulated proteins are located in the upper left (green). C, Panther
protein classification. Shown are the protein classifications for the secreted proteins in the R. conorii-infected HUVECs. D, IPA network.
Shown is the top-ranked network (“immunological disease”) of soluble Golgi proteins from IPA. Abbreviations are shown in Table IV.
TABLE IV
Soluble Golgi proteins
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TABLE V
R. conorii proteins identified
Each protein is identified with FDR of 	1%. For each protein, the subcellular fraction in which it was identified is shown.
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proteins, we developed quantitative high throughput SRM
assays to selectively measure each protein. The proteins,
gene names, and accession numbers are shown in Table VI.
The optimal empirically determined collision energy is also
tabulated. Compared with LPS-stimulated cells, significant
induction of STAT1 and ISG15 was observed in the WCL
(Fig. 6A).
We also selected candidate rickettsial proteins identified in
the Golgi and PM fractions as follows: the putative UvrABC
system protein C; putative ankyrin repeat protein RBE; and
chaperone protein HtpG. Compared with LPS-stimulated
cells, significant induction of each was observed (Fig. 6B). The
up-regulation of HLA proteins and the rickettsial proteins
UVRVC and HPTG in the soluble Golgi fraction was also
confirmed with SID-SRM-MS (Fig. 6C).
DISCUSSION
Rickettsiae are non-motile, Gram-negative, and obligately
intracellular bacterial pathogens of global medical and veter-
inary health importance. During transmission, an infected he-
matophagous arthropod vector introduces rickettsiae into the
dermis, where the organism disseminates to vascular endo-
thelial cells throughout the body. Here, dividing Rickettsia
induce cellular stress leading to cell detachment. Detached
endothelial cells, which are heavily infected, lodge into down-
stream capillaries and initiate new foci of vascular infection. In
our approach, we harvested infected endothelial cells once
they were homogeneously infected, which mimic these foci of
vascular infection. Such multifocal lesions are found through-
out the course of the disease, even at early stages. We
applied subcellular fractionation and quantitative proteomics
to develop an integrated understanding of the human endo-
thelial cellular response and subcellular distribution of Rick-
ettsia proteins in this model of established infection. We de-
duced the activation of the JAK-STAT-ISG15 signaling
pathway along with significant perturbations of cell surface
enzymatic activities of infected endothelial cells. We think it
important that R. conorii-infected endothelial cells show sig-
nificant down-regulation of cadherin components whose pu-
tative role in pathogenesis is discussed below.
Previous work by us has shown that the IFN response is a
major determinant limiting severity of rickettsial disease in
vivo (33, 34). Although the pattern recognition receptors for
rickettsial infection are not fully understood, replication of
Rickettsia is a stimulus for production of type I IFN (IFN) (35).
The type I IFN response has been observed as a common
response to Rickettsia infections for all endothelial cell types
TABLE VI
SID-SRM-MS assays for human and rickettsial proteins
For each protein, the proteotypic peptide (sequence) is shown, along with the mass to charge ratio (m/z) for the first quadrupole (Q1) and
third quadrupole (Q3) measurement, the ion type, and optimized collision energy.
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examined (36). Downstream of IFN, activation of the STAT1
signaling pathway triggers production of ISG, MX1, SOCS,
and other proteins important in host defense (37). ISG15 is a
small ubiquitin-like modifier induced at the transcriptional
level by IFN signaling known to covalently modify target pro-
teins by ISGylation, inducing changes in signaling, che-
motaxis, and translation. In human microvascular endothelial
cells infected with R. conorii, ISG15 is up-regulated through
FIG. 6. Qualification of innate response proteins in R. conorii-infected HUVECs. A, qualification of IFN pathway. Shown are SID-selected
reaction-monitoring (SRM)-MS measurements of STAT1 and ISG15 (bottom) for HUVEC stimulated with LPS (left) or infected with R. conorii
(right). y axis is ratio of protein relative to internal SIS peptide (native/SIS) peptide (native/aqua). B, qualification of rickettsial proteins in Golgi
membranes. SID-SRM-MS measurements for UvrABC system protein C are shown; putative ankyrin repeat protein RBE; and chaperone
protein HtpG. Compared with LPS-stimulated cells, significant induction of each was observed. C, qualification of rickettsial proteins in soluble
Golgi fraction. SID-SRM-MSmeasurements for human HLA proteins and the rickettsial proteins UVRVC and HPTG in the soluble Golgi fraction.
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an IFN--dependent pathway, and it controls intracellular
rickettsial replication (35). Our data extend the Rickettsia-
induced IFN pathway to include intracellular MX1 and cell-
surface associated IFITM3 expression. More study will be
required to understand their role, if any, in restricting rickett-
sial infection.
Previous work has shown that E-selectin (11), VCAM-1,
ICAM-1 (11–13), and V3 integrin (14) are plasma membrane
proteins up-regulated in Rickettsia-infected cells to mediate
neutrophil attachment, as well as vascular integrity. Because
of their size, hydrophobic characteristics, and insolubility, the
analysis of PM proteins is typically challenging. In this study,
we applied a cell surface-directed biotin cross-linking method
to affinity-enrich PM proteins in Rickettsia-infected cells. This
method enables the enrichment and quantitation of integral
PM proteins (18). Our data suggest that rickettsial infection
up-regulates voltage channels in endothelial cell and depletes
plasma membrane-associated ACTA1. Such changes could
underlie vascular reactivity and the phenomenon of endothe-
lial cell detachment (38), which could be a source of new foci
of infection once they lodge in distal capillaries.
Previous studies provided evidence that T lymphocytes are
critical in the development of immune protection in rickettsial
disease; CD4 and CD8 T lymphocytes protect mice against
lethal disseminated endothelial infection with R. conorii (39),
but CD8 T cells are the most critical effectors (40). We note
that up-regulation of HLA-I antigen transporter is observed,
along with the presence of 2-microglobulin, hydrolases, and
Rickettsia OmpB (Sca5) and Sca2 in the secretory pathway
(soluble Golgi fraction). Importantly, OmpB is an immu-
nodominant antigen for CD8 T lymphocytes in a mouse model
of R. conorii infection (41). These data may explain how this
immunodominant rickettsial antigen is processed and pre-
sented to the PM.
von Willebrand factor (vWF), an adhesive glycoprotein in-
volved in primary hemostasis, is primarily stored in endothelial
secretory granules, Weibel-Palade bodies, from which it is
released during rickettsial infection (42). We observe in-
creased abundance of vWF in R. conorii-infected endothelial
cells. These data may suggest that newly synthesized vWF is
processed by the Golgi apparatus prior to its packaging within
the Weibel-Palade body.
Analysis of the soluble fraction of Golgi-enriched organelles
provides a number of insights into the host response of en-
dothelial cells. Endothelial host response proteins are highly
enriched in MHC class I activity, including HLA-A, -C, and
2-microglobulin. Interestingly, Rickettsia cell surface anti-
gens, Sca-5 and -2, are found in the secretory pathway, which
may be a reflection of antigenic processing for presentation
through the MHC class I pathway. Previous work by us has
shown that MHC I knockout mice are highly susceptible to
rickettsial infection due to defects in mobilizing an efficient
cytotoxic T cell response (40). Interestingly, we have observed
that cathepsin is an abundant cysteine protease enriched in
the secretory fraction. Cathepsin has recently been shown to
be involved in proteolytic processing of chemerin to trigger
migration of human blood-derived plasmacytoid dendritic
cells (43). Whether cathepsin plays a role in host response to
Rickettsia infection may be an important direction for future
research.
Our experimental design was intended to identify the major
responses of human endothelial cells to established rickettsial
infection. In our design, we harvested infected endothelial
cells once they were homogeneously infected, a model that
mimics foci of vascular infection from detached endothelial
cells important in rickettsial dissemination. Other mechanistic
studies have shown rapid activation of STAT3 signaling within
hours of rickettsial infection, followed by a later activation of
STAT1 (44). More work will be required to understand the
early patterns of host response in rickettsial infection.
In summary, our study provides an integrated host and
bacterial proteomics analysis of the infection of primary hu-
man endothelial cells with the etiologic agent of human Med-
iterranean spotted fever, R. conorii. Our study identifies the
STAT1-ISG15 and HLA antigen production as the major com-
ponents of the innate and adaptive immune response trig-
gered by endothelial cells. We observe significant reprogram-
ming of the plasma membrane proteome and induction of
adhesion molecules, with down-regulation of endothelial cell
cadherins. These observations generate insights into how
rickettsiae induce the endothelial stress response.
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